Critical Analysis: Teleflex (NYSE:TFX) versus WORK Medical Technology Group (NASDAQ:WOK)

WORK Medical Technology Group (NASDAQ:WOK) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability.

Profitability

This table compares WORK Medical Technology Group and Teleflex’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
WORK Medical Technology Group	N/A	N/A	N/A
Teleflex	-10.28%	15.64%	8.71%

Analyst Ratings

This is a summary of current ratings and recommmendations for WORK Medical Technology Group and Teleflex, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WORK Medical Technology Group	1	0	0	0	1.00
Teleflex	2	8	2	0	2.00

Teleflex has a consensus target price of $141.88, indicating a potential upside of 34.70%. Given Teleflex’s stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than WORK Medical Technology Group.

Institutional & Insider Ownership

95.6% of Teleflex shares are owned by institutional investors. 1.4% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares WORK Medical Technology Group and Teleflex”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WORK Medical Technology Group	$11.51 million	0.00	-$3.49 million	N/A	N/A
Teleflex	$3.05 billion	1.53	$69.68 million	($7.35)	-14.33

Teleflex has higher revenue and earnings than WORK Medical Technology Group.

Risk & Volatility

WORK Medical Technology Group has a beta of 3.63, meaning that its share price is 263% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.

Summary

Teleflex beats WORK Medical Technology Group on 10 of the 12 factors compared between the two stocks.

About WORK Medical Technology Group

WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.